Assessment of Adverse Renal Effects in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin

被引：0
|
作者：
Patel, Shrita M.
Hickman, Mary A.
Frederich, Robert
Lauring, Brett
Terra, Steven
Johnson, Susan L.
Huyck, Susan
Mancuso, James P.
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-1168-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Assessment of adverse renal effects in patients with type 2 diabetes receiving ertugliflozin
    Terra, S. G.
    Patel, S.
    Hickman, A.
    Frederich, R.
    Lauring, B.
    Johnson, S.
    Huyck, S.
    Mancuso, J. P.
    [J]. DIABETOLOGIA, 2018, 61 : S300 - S301
  • [2] Evaluation of Osmotic Diuresis and Volume Depletion Events in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Patel, Shrita M.
    Hickman, Mary A.
    Frederich, Robert
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Huyck, Susan
    Mancuso, James P.
    [J]. DIABETES, 2018, 67
  • [3] Efficacy and Safety of Ertugliflozin across Racial Groups in Patients with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Pong, Annpey
    Huyck, Susan
    Wu, Larry
    Mancuso, James P.
    Terra, Steven
    Lauring, Brett
    [J]. DIABETES, 2018, 67
  • [4] Efficacy and Safety of Ertugliflozin in Hispanic/Latino Patients (Pts) with Type 2 Diabetes Mellitus (T2DM)
    Liu, Jie
    Tarasenko, Lisa
    Ellison, Misoo C.
    Pong, Annpey
    Huyck, Susan
    Mancuso, James P.
    Terra, Steven G.
    Gantz, Ira
    [J]. DIABETES, 2019, 68
  • [5] Evaluation of Fractures, Bone Mineral Density (BMD), and Bone Biomarkers in Patients with Type 2 Diabetes Mellitus (T2DM) Receiving Ertugliflozin
    Hickman, Mary A.
    Frederich, Robert
    Patel, Shrita M.
    Gallo, Silvina
    Lauring, Brett
    Terra, Steven
    Johnson, Susan L.
    Masiukiewicz, Urszula
    Huyck, Susan
    Mancuso, James P.
    [J]. DIABETES, 2018, 67
  • [6] Population Pharmacokinetic (POPPK) Model for Ertugliflozin in Healthy Subjects and Type 2 Diabetes Mellitus (T2DM) Patients
    Fediuk, Daryl J.
    Sweeney, Kevin
    Zhou, Susan
    Kumar, Vikas
    Sahasrabudhe, Vaishali
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S25 - S25
  • [7] Empagliflozin in Patients With Type 2 Diabetes Mellitus (T2DM) and Renal Impairment (RI)
    Barnett, Anthony H.
    Mithal, Ambrish
    Manassie, Jenny
    Jones, Russell
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A286 - A286
  • [8] ASSESSMENT OF LIVER FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS RECEIVING ERTUGLIFLOZIN
    Gallo, Silvina
    Calle, Roberto
    Terra, Steven
    Pong, Annpey
    Tarasenko, Lisa
    Raji, Annaswamy
    [J]. HEPATOLOGY, 2019, 70 : 1261A - 1261A
  • [9] Regional effects of type 2 diabetes mellitus (T2DM) on neurodegeneration
    Moran, C.
    Phan, T. G.
    Beare, R. J.
    Chen, J.
    Blizzard, L.
    Venn, A.
    Greenaway, T.
    Munch, G.
    Forbes, J.
    Pearson, S.
    Srikanth, V
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2012, 7 : 20 - 20
  • [10] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
12345